✦ LIBER ✦
Which performance status is prognostically superior to IPI in patients treated with oral chemotherapy with and without rituximab for diffuse large B-cell lymphoma (DLBCL) in elderly patients unsuitable for anthracycline chemotherapy
✍ Scribed by Kruger⁎, A.; Edwards, C.; Rust, K.; Kruger, R.
- Book ID
- 122376548
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 196 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1879-4068
No coin nor oath required. For personal study only.